Total Payments
$3,567
2024 Payments
$1,391
Companies
8
Transactions
47
Medicare Patients
2,210
Medicare Billing
$323,646
Payment Breakdown by Category
Other$1,305 (36.6%)
Food & Beverage$1,262 (35.4%)
Consulting$1,000 (28.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $1,305 | 1 | 36.6% |
| Food and Beverage | $1,262 | 45 | 35.4% |
| Consulting Fee | $1,000 | 1 | 28.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $1,948 | 24 | $0 (2023) |
| Amgen Inc. | $1,333 | 13 | $0 (2024) |
| BIOTISSUE HOLDINGS, INC. | $109.53 | 3 | $0 (2023) |
| REVANCE THERAPEUTICS, INC. | $57.85 | 1 | $0 (2024) |
| Shire North American Group Inc | $36.45 | 2 | $0 (2017) |
| MERZ NORTH AMERICA, INC. | $29.72 | 1 | $0 (2017) |
| Allergan, Inc. | $29.51 | 2 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $22.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,391 | 14 | Amgen Inc. ($1,333) |
| 2023 | $535.91 | 16 | Horizon Therapeutics plc ($426.38) |
| 2022 | $1,472 | 8 | Horizon Therapeutics plc ($1,449) |
| 2021 | $72.46 | 4 | Horizon Therapeutics plc ($72.46) |
| 2020 | $15.20 | 1 | Allergan, Inc. ($15.20) |
| 2019 | $14.31 | 1 | Allergan Inc. ($14.31) |
| 2017 | $66.17 | 3 | Shire North American Group Inc ($36.45) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $139.57 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $32.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/19/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $9.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/03/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/02/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/16/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $57.85 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 04/01/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/29/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/07/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/01/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: TEPEZZA | ||||||
| 11/10/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: TEPEZZA | ||||||
| 11/03/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: TEPEZZA | ||||||
| 09/06/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: TEPEZZA | ||||||
| 08/23/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: TEPEZZA | ||||||
| 08/21/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
| 07/27/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $113.54 | General |
| Category: TEPEZZA | ||||||
| 07/24/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: TEPEZZA | ||||||
| 07/11/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $9.98 | General |
| Category: TEPEZZA | ||||||
| 06/07/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: TEPEZZA | ||||||
| 05/29/2023 | BIOTISSUE HOLDINGS, INC. | PROKERA (Device), AMNIOGRAFT | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: HUMAN TISSUE PRODUCTS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 635 | 723 | $214,790 | $82,152 |
| 2022 | 13 | 684 | 755 | $258,417 | $94,681 |
| 2021 | 12 | 546 | 624 | $274,925 | $94,173 |
| 2020 | 10 | 345 | 402 | $150,847 | $52,640 |
Total Patients
2,210
Total Services
2,504
Medicare Billing
$323,646
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 67904 | Repair of tendon of upper eyelid | Facility | 2023 | 31 | 31 | $52,950 | $20,225 | 38.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 89 | 89 | $33,375 | $13,984 | 41.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 146 | 208 | $31,200 | $13,192 | 42.3% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 17 | 17 | $25,000 | $9,533 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 78 | 95 | $21,375 | $8,754 | 41.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $17,400 | $6,864 | 39.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 35 | $13,475 | $4,174 | 31.0% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 65 | 68 | $10,000 | $2,287 | 22.9% |
| 92285 | Photography of content of eyes | Office | 2023 | 74 | 76 | $3,420 | $1,304 | 38.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 20 | $2,500 | $817.38 | 32.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 13 | $2,275 | $617.63 | 27.1% |
| 92134 | Imaging of retina | Office | 2023 | 12 | 13 | $1,820 | $400.14 | 22.0% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 35 | 35 | $53,402 | $20,566 | 38.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 123 | 123 | $46,125 | $18,906 | 41.0% |
| 67904 | Repair of tendon of upper eyelid | Facility | 2022 | 29 | 29 | $43,650 | $18,507 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 165 | 226 | $33,900 | $13,047 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $9,300 | $4,035 | 43.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 34 | $13,090 | $3,990 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 37 | $8,325 | $3,578 | 43.0% |
| 67917 | Extensive repair of turning-outward eyelid defect | Facility | 2022 | 12 | 13 | $15,600 | $3,029 | 19.4% |
| 92082 | Exam of visual field with intermediate testing | Office | 2022 | 79 | 81 | $14,075 | $2,783 | 19.8% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 11 | 11 | $7,995 | $2,418 | 30.2% |
| 92285 | Photography of content of eyes | Office | 2022 | 98 | 99 | $4,455 | $1,662 | 37.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 22 | 22 | $6,050 | $1,623 | 26.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 13 | 14 | $2,450 | $535.70 | 21.9% |
About Dr. Syed Ahmad, M.D
Dr. Syed Ahmad, M.D is a Specialist healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700950383.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Syed Ahmad, M.D has received a total of $3,567 in payments from pharmaceutical and medical device companies, with $1,391 received in 2024. These payments were reported across 47 transactions from 8 companies. The most common payment nature is "Honoraria" ($1,305).
As a Medicare-enrolled provider, Ahmad has provided services to 2,210 Medicare beneficiaries, totaling 2,504 services with total Medicare billing of $323,646. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Ophthalmology
- Location Plano, TX
- Active Since 11/17/2006
- Last Updated 01/13/2021
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1700950383
Products in Payments
- TEPEZZA (Drug) $1,948
- TEPEZZA (Biological) $1,333
- PROKERA (Device) $109.53
- XIIDRA (Drug) $59.30
- DAXXIFY (Drug) $57.85
- Xeomin (Biological) $29.72
- BOTOX COSMETIC (Biological) $29.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Plano
F. Barber, M.d, M.D
Specialist — Payments: $362,181
Specialist $362,181
Dr. Frances Herbert, M.d, M.D
Specialist — Payments: $110,457
Specialist $110,457
Dr. Rajesh Arakal, M.d, M.D
Specialist — Payments: $100,281
Specialist $100,281
Dr. Jeffrey Adelglass, M.d, M.D
Specialist — Payments: $39,291
Specialist $39,291
Dr. Robert Wilcox, Md Pa, MD PA
Specialist — Payments: $25,752
Specialist $25,752
Dr. Aaron Bransky, Md, MD
Specialist — Payments: $25,257
Specialist $25,257